Gene · 54795
Papers1,538
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,538
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of TRPM4 related genes in LUAD by RNA seq and spatial transcriptomics. | Discov Oncol | 2026 | 41845138 | PubTator, text mining | PubMed |
| Identification of 14-3-3 Proteins as Binding Partners of TRP Channels. | J Chem Inf Model | 2026 | 41839059 | PubTator, text mining | PubMed |
| Comprehensive bioinformatic analysis reveals TRPM4 as a biomarker for pan-cancer progression and macrophage infiltration. | Discov Oncol | 2026 | 41811367 | PubTator, text mining | PubMed |
| Molecular hydrogen triggers TRPC4-TRPC4AP-dependent reversible calcium transients via extracellular influx. | Theranostics | 2026 | 41799190 | PubTator, text mining | PubMed |
| Modulation of NMDA Receptor and TRPM4 Activity in Hippocampal Neurons with the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin. | Neurotox Res | 2026 | 41790165 | PubTator, text mining | PubMed |
| Cardiac Manifestations of KCNK17 Mutations and/or Polymorphisms: A Systematic Review. | Health Sci Rep | 2026 | 41782661 | PubTator, text mining | PubMed |
| Correction: Development of a novel prognostic model based on TRPM4-Induced sodium overload-mediated cell death in kidney cancer. | Front Cell Dev Biol | 2026 | 41777600 | PubTator, text mining | PubMed |
| Construction of a Prognostic Model for Lung Adenocarcinoma Based on Necrosis by Sodium Overload-Related Genes and Identification of DENND1C as a New Prognostic Marker. | Curr Issues Mol Biol | 2026 | 41751408 | PubTator, text mining | PubMed |
| Clinical Evaluation of Neonatal Arrhythmias: Experience from a Specialized Pediatric Cardiac Center. | J Cardiovasc Dev Dis | 2026 | 41745313 | PubTator, text mining | PubMed |
| Multi-omics profiling of sodium-overload (NECSO) programs identifies NEK8 as a central driver of colorectal cancer progression through single-cell and spatial transcriptomics. | Front Immunol | 2026 | 41743703 | PubTator, text mining | PubMed |
| Editorial: New insights into gut microbiota in colorectal cancer. | Front Cell Infect Microbiol | 2026 | 41716463 | PubTator, text mining | PubMed |
| Systematic Druggable Genome-Wide Mendelian Randomization Identifies Genetically Supported Therapeutic Targets for Coronary Artery Disease. | Curr Med Chem | 2026 | 41691680 | PubTator, text mining | PubMed |
| Temperature and intrinsic Ca 2+ reshape TRPM4 pharmacology. | bioRxiv | 2026 | 41676511 | PubTator, text mining | PubMed |
| Structural mechanism of Necrocide 1 activation of human TRPM4 that triggers necrosis by sodium overload. | bioRxiv | 2026 | 41659621 | PubTator, text mining | PubMed |
| Targeting Hsp70 triggers ferroptosis: a novel anti-cancer mechanism of a marine natural product in prostate cancer. | Nat Prod Bioprospect | 2026 | 41639515 | PubTator, text mining | PubMed |
| Just a little prick: careful cell contacts enabled by ceramic nanostraws. | Pflugers Arch | 2026 | 41622290 | PubTator, text mining | PubMed |
| Extracellular acidity and ATP modulate ion currents in human cumulus cells indicating possible roles as metabolic sensors of the follicular microenvironment. | Physiol Rep | 2026 | 41603488 | PubTator, text mining | PubMed |
| Mass Spectrometry Proteomics: A Key to Faster Drug Discovery. | J Med Chem | 2026 | 41433248 | PubTator, text mining | PubMed |
| Inhibition of the TRPM4 channel by 9-PH attenuates hippocampal endothelial injury induced by sleep deprivation and the subsequent neuroinflammation and neurological dysfunction. | Exp Neurol | 2026 | 41349672 | PubTator, text mining | PubMed |
| SUR1-TRPM4 is expressed in human epilepsy and promotes neuron hyperactivity and seizures in rodents. | Brain | 2026 | 41239869 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54795/papers?page=3